Age-Dependent Effect of Disease-Modifying Therapy on Cancer Risk in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort study
Mult Scler Relat Disord 2023 Dec 01;[EPub Ahead of Print], J Greenfield, LM Metz, A Khakban, ER Llorian, KD Michaux, A Traboulsee, J Oh, P Smyth, LD Lynd, AGM Bulloch, JVA Williams, SB PattenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.